Pierre Roubertoux

Prof. Pierre Roubertoux


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ACAnnaëlle Charrier
Annaëlle Charrier
BOBertrand Olliac
Bertrand Olliac
PRPierre Roubertoux
Pierre Roubertoux
STSylvie Tordjman
Sylvie Tordjman
In mammals, the circadian clocks network (central and peripheral oscillators) controls circadian rhythms and orchestrates the expression of a range of downstream genes, allowing the organism to anticipate and adapt to environmental changes. Beyond their role in circadian rhythms, several studies have highlighted that circadian clock genes may have a more widespread physiological effect on cognition, mood, and reward-related behaviors. Furthermore, single nucleotide polymorphisms in core circadian clock genes have been associated with psychiatric disorders (such as autism spectrum disorder, schizophrenia, anxiety disorders, major depressive disorder, bipolar disorder, and attention deficit hyperactivity disorder). However, the underlying mechanisms of these associations remain to be ascertained and the cause–effect relationships are not clearly established. The objective of this article is to clarify the role of clock genes and altered sleep–wake rhythms in the development of psychiatric disorders (sleep problems are often observed at early onset of psychiatric disorders). First, the molecular mechanisms of circadian rhythms are described. Then, the relationships between disrupted circadian rhythms, including sleep–wake rhythms, and psychiatric disorders are discussed. Further research may open interesting perspectives with promising avenues for early detection and therapeutic intervention in psychiatric disorders.

15 February 2017 in Behavior Genetics
Verified
Journal Article
Closed access
PDF file
PRPierre Roubertoux
Pierre Roubertoux
NBNathalie Baril
Nathalie Baril
PCPierre Cau
Pierre Cau
CSChristophe Scajola
Christophe Scajola
AGAdeline Ghata
Adeline Ghata
MCMichèle Carlier
Michèle Carlier

1 January 1999
Verified
Book Chapter
Closed access
PRPierre Roubertoux
Pierre Roubertoux
IRIsabelle Le Roy
Isabelle Le Roy
SMStephane Mortaud
Stephane Mortaud
FPFernando Perez-Diaz
Fernando Perez-Diaz
STSylvie Tordjman
Sylvie Tordjman

22 December 2014
Verified
Book Chapter
Closed access
PRPierre Roubertoux
Pierre Roubertoux
MCMichèle Carlier
Michèle Carlier
STSylvie Tordjman
Sylvie Tordjman

27 February 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
TSTordjman Sylvie
Tordjman Sylvie
ACAnnaëlle Charrier
Annaëlle Charrier
MKMichel Kazatchkine
Michel Kazatchkine
PRPierre Roubertoux
Pierre Roubertoux
MBMichel Botbol
Michel Botbol
SAStratis Avrameas
Stratis Avrameas
Background: Many and diverse autoimmune abnormalities have been reported in children with autism. Natural autoantibodies (NAAbs) play important immunoregulatory roles in recognition of the immune self. The objective of this study was to examine the presence of NAAbs in the sera of children with autism and across severity subgroups of autistic behavioral impairments. Methods: NAAbs were titrated in sera through an ELISA procedure in 60 low-functioning children with autism and 112 typically developing controls matched for age, sex and puberty. Results: Serum titers of IgG anti-F(ab’)2 autoantibodies were significantly lower in children with autism compared to typically developing controls (p < 0.0001), and were significantly negatively associated with autism severity (p = 0.0001). This data appears to be related more specifically to autism than to intellectual disability, given that IgG anti-F(ab’)2 levels were significantly negatively correlated with IQ scores in the autism group (p = 0.01). Conclusions: This is the first report in autism of abnormally low natural anti-F(ab’)2 autoantibody activity. The findings suggest a dysfunction of self-recognition mechanisms which may play a role in the pathogenesis of autism, especially for the severely affected children. These findings strengthen the hypothesis of an autoimmune process in autism and open the prospect of alternative medical treatment. Further neuroimmunological research is warranted to understand the exact mechanisms underlying this reduced natural IgG anti-F (ab’)2 autoantibody activity, and to assess its impact on the pathophysiology and behavioral expression of autism.

22 December 2014
Verified
Book Chapter
Closed access
NLNicolas Levy
Nicolas Levy
PRPierre Roubertoux
Pierre Roubertoux